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Mutations in the human laminin 2 (LAMA2) gene result in the
most common form of congenital muscular dystrophy (MDC1A).
There are currently three models for the molecular basis of cellular
pathology in MDC1A: (i) lack of LAMA2 leads to sarcolemmal
weakness and failure, followed by cellular necrosis, as is the case
in Duchenne muscular dystrophy (DMD); (ii) loss of LAMA2-medi-
ated signaling during the development andmaintenance ofmuscle
tissue results in myoblast proliferation and fusion defects; (iii) loss
of LAMA2 from the basement membrane of the Schwann cells
surrounding the peripheral nerves results in a lack of motor
stimulation, leading to effective denervation atrophy. Here we
show that the degenerative muscle phenotype in the zebrafish
dystrophic mutant, candyfloss (caf) results from mutations in the
laminin 2 (lama2) gene. In vivo time-lapse analysis of mechani-
cally loaded fibers and membrane permeability assays suggest
that, unlike DMD, fiber detachment is not initially associated with
sarcolemmal rupture. Early muscle formation and myoblast fusion
are normal, indicating that any deficiency in early Lama2 signaling
does not lead to muscle pathology. In addition, innervation by the
primary motor neurons is unaffected, and fiber detachment stems
from muscle contraction, demonstrating that muscle atrophy
through lack of motor neuron activity does not contribute to
pathology in this system. Using these and other analyses, we
present a model of lama2 function where fiber detachment exter-
nal to the sarcolemma is mechanically induced, and retracted fibers
with uncompromised membranes undergo subsequent apoptosis.
muscle  degeneration  fiber  time-lapse
Congenital muscular dystrophies (CMDs) are a group ofneuromuscular disorders characterized by severe hypotonia,
muscle weakness, and contractures (1). The incidence of CMDs
has been estimated to be approximately one in 21,500 (2), with
laminin 2- (LAMA2) deficient CMD (MDC1A) accounting for
40–50% of the CMD cases in European countries (3). MDC1A
is caused by genetic lesions in the LAMA2 gene (4). The classical
phenotype is associated with complete LAMA2 deficiency and
pathological symptoms of muscle degeneration, fibrosis, and
white matter abnormalities within the CNS (5).
Laminins are major structural components of basal laminae
and exist as heterotrimeric complexes of one , one , and one
 chain. Specific complexes exhibit particular tissue specificities.
There are currently 15 describedmammalian complexesmade up
of varying combinations of five , three , and three  chains (6,
7). In addition to their structural role, laminins also act as
signaling molecules through receptors such as integrins (8). The
most-studied complex to date has been laminin 1, largely for
historical reasons, because it was the first to be identified.
Laminin 1 consists of the laminin 1, 1, and 1 chains. It
appears early in epithelial morphogenesis in most embryonic
tissues and is a major component of extracellular matrix (ECM)
(9). In the zebrafish, the 1, 1, and 1 chains that make up the
laminin 1 complex are essential for normal embryonic develop-
ment and have been shown to be particularly important in
notochord morphogenesis and maintenance (10, 11). Work in
mammalian systems has shown that the 2 subunit is present
in three complexes; laminins 2 and 4, expressed in the basal
laminae of muscle fibers, and the Schwann cells surrounding the
peripheral nerves (6, 12, 13); and laminin 12, a little-studied
complex that is potentially the first non-basement membrane
laminin (14).
Different hypotheses have been developed as to why LAMA2
deficiency leads to the onset of CMD. Most commonly, the
proposed mechanism of cellular pathology centers on the struc-
tural role of LAMA2, through its interaction with the dystro-
phin-associated glycoprotein complex (DGC), necessary for
maintenance of sarcolemmal integrity (15). LAMA2 is known to
bind directly to -dystroglycan, the component of the DGCmost
distal to the sarcolemma, and thereby to anchor the muscle cell
membrane to the ECM (16). The notion of a structural link from
the ECM through to the actin cytoskeleton being provided by the
DGC is strengthened by the observation that a number of
degenerative diseases of the skeletal muscle, including Duch-
enne muscular dystrophy (DMD) and certain limb girdle mus-
cular dystrophies, are associated with abnormalities in compo-
nents of the DGC (17). Traditionally, the accepted dogma
regarding the cellular pathology of these diseases has been that
loss of the structural link between the internal actin cytoskeleton
and the cell membrane renders the sarcolemma vulnerable to
mechanical damage that, in turn, leads to fiber apoptosis and/or
necrosis [dystrophin (18) and -sarcoglycan (19)]. However, in
recent years, mechanistic explanations of dystrophic pathologies
have been challenged by hypotheses suggesting that signaling
dysfunction could be more important than loss of sarcolemmal
integrity. For instance, dystrophin, in addition to its structural
role, serves as a scaffold for the assembly of a multicomponent
signal transduction complex, members of which also form inte-
gral parts of the DGC (20). In the case of LAMA2, both
mechanistic and dysfunctional signaling explanations have been
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mooted for the pathology of MDC1A because, in vitro at least,
laminin-integrin binding is involved in the regulation of myoblast
proliferation and fusion (21). However, the laminin 2 complex is
not strictly a DGC member and is found external to the
sarcolemma, forming a link between the DGC and the ECM. As
such, it is unclear whether fiber detachment and/or loss of
membrane integrity contribute significantly to the pathology. In
addition, LAMA2-deficient CMD is not normally associated
with loss of DGC components or of dystrophin itself (5). Also
unlike DMD,MDC1A involves peripheral nerve defects, leading
to a third hypothesis, that impaired neural function results in
relatively little electrical stimulation and contraction of myofi-
bers, effectively causing denervation atrophy (7). Thus, the
actual basis of the pathology evident in LAMA2-deficient CMD
remains to be determined.
Here, we describe two null alleles of lama2 in the zebrafish, in
which we directly observe muscle pathology in real time by using
time-lapse photomicroscopy. Our analyses lead to hypotheses of
lama2 function that are likely clinically significant. We clearly
show that in the zebrafish model of MDC1A, the primary
mechanism of pathology is through fiber detachment induced by
mechanical loading of the fiber. In contrast to models of DMD,
this fiber detachment occurs in the absence of major sarcolem-
mal disruption or loss of components of the DGC. Using
transmission electron microscopy, we demonstrate a loss of
integrity of the ECM and subsequent fibrosis. In addition, we
show that early myoblast proliferation and fusion are unaffected,
confirming that in this model, loss of Lama2 does not lead to
muscle differentiation abnormalities. Similarly, formation and
function of the primary motor neurons are normal, and we find
no difference in innervation between homozygous caf embryos
and siblings. Furthermore, fiber detachment depends on motor
activity, leading us to conclude that peripheral nerve defects also
do not contribute to pathology in this system.
Results
Identification of the candyfloss Locus. The dystrophic mutants
[class A4 (22)] from the Tubingen screen are characterized by
muscle degeneration shortly after formation. They have im-
pairedmotility in the early larval phase and show reducedmuscle
birefringency under polarized light. Complementation was per-
formed between mutants sapjeta222a (sap), softy tm272a, and ‘‘un-
resolved’’ alleles tf212b, teg15a, and tk209. Of these, only teg15a
and tk209 were found to be in the same complementation group
and distinct from already-defined loci. We named this dystrophic
mutant candyfloss (caf teg15a, caf tk209), because of the severe
nature of the progressive muscle loss and the shape of dystrophic
muscle fibers evident in homozygous mutants. The gross phe-
notype of the two caf alleles was indistinguishable. Conse-
quently, all phenotypic analysis was performed on caf teg15a.
Initial formation of myotomal muscle is normal in caf embryos
(Fig. 1A). However, immunohistochemistry using antibodies
against slow and fast myosin heavy chains revealed that at 36 h
postfertilization (hpf), shortly after elongation and fusion of
myofibers, the first pathology becomes evident (Fig. 1 B and C).
The dystrophic appearance of the muscle is caused by detach-
ment and retraction of muscle fibers from the vertical myosepta
that form the somite boundaries. Detachment first occurs in the
slow muscle layer at the periphery of the myotome, which are the
first fibers in the embryo to differentiate and function (Fig. 1B).
This is closely followed by detachment in the deeper fast muscle
layer (Fig. 1C). In live embryos, the caf phenotype is first visible
under differential interference contrast microscopy (DIC) at 48
hpf. At this time, the first myotomal lesions can be seen in a small
proportion of embryos within a clutch. There is some variability
in the severity of the phenotype among homozygotes, and the
phenotype becomes fully penetrant only after 72 hpf, around the
time of hatching (Fig. 1D). Mutant embryos often need to be
manually dechorionated at this time, because many are unable to
extricate themselves and otherwise die within the chorion.
Muscle damage does not affect all somites equally. Whereas a
particular somite may appear normal, its neighbor might contain
virtually no intact fibers. Such stochastic fiber damage is a
hallmark of muscular dystrophy of human patients and mam-
malian animal models alike, as well as the dystrophin-deficient
zebrafish mutation sap. The majority of mortality was found to
occur suddenly around days 14–16. However, a small number of
homozygote mutants survived this critical period and reached
adulthood (2/80), although these individuals have so far failed to
reproduce [supporting information (SI) Fig. 7].
Muscle Fiber Detachment Is Induced byMotor Activity.The stochastic
pattern of muscle damage between somites led us to investigate
whether muscle damage was related to motor activity. Raising
embryos under anesthetic resulted in complete suppression of
the phenotype up to 72 hpf (SI Table 1). Conversely, mechan-
ically overloading the muscle of mutant larvae greatly increased
both the severity and incidence of the fiber pathology within
these animals. Mechanical loading of fibers was achieved by
stimulating larvae to swim through raising media to which had
been added the inert cellulose polymer, methyl-cellulose, which
increased the viscosity of the surrounding media through which
the larvae were required to swim. Raising embryos in 0.6%
methyl-cellulose led to an increased severity of phenotype, with
caf homozygous mutants displaying detached fibers in virtually
every somite (SI Tables 1 and 2). The nature of this fiber loss
could be captured in real time by the use of an anesthetic
recovery protocol. Mutants previously anesthetized in 0.001%
tricaine were transferred into a highly viscous 3% methyl-
cellulose solution, dissolved in raising media that contained no
anesthetic. Upon anesthetic recovery, the partially immobilized
muscle began to contract against the high viscosity of the
mounting media inducing a rapid fiber pathology. Fiber detach-
ment induced under these conditions could be visualized by
using time-lapse photomicroscopy (Fig. 1E and SI Movie 1). It
is clear from these analyses that the phenotype of homozygous
caf mutants results from contraction-induced fiber detachment
from the ends of the muscle fibers, and that the severity of this
Fig. 1. Initial muscle formation and degeneration in caf embryos. (A)
Myoblasts fuse and elongate to form multinucleate fibers (arrowheads) that
span the myotome between vertical myosepta. Single confocal scan through
epaxial somite at 36 hpf. Green, f310 anti-fast MyHC; red, propidium iodide.
(B) Degeneration in the slow layer, which is the first to elongate and fuse.
Confocal projection of somite at 36 hpf. f59 anti-slow MyHC. (C) Degeneration
in the deeper fast muscle layer. Arrowhead indicates a site of fiber loss.
Confocal projection of somite at 36 hpf, f310 anti-fast MyHC. (D) Myotomal
lesions at 72 hpf. DIC brightfield image of epaxial somite. (E) Stills from a
time-lapse DIC movie showing fiber detachment and retraction in a homozy-
gous caf embryo at 72 hpf, captured by using the anesthetic recovery tech-
nique. Time is indicated in seconds. The full movie sequence is available as SI
Movie 1. In all images, anterior is to the left.














detachment phenotype is proportional to the load under which
muscle fibers are placed.
Fiber Detachment Is Not Associated with Loss of Sarcolemmal Integ-
rity. The similarity of the caf phenotype to models of DMD led
us to investigate whether sarcolemmal integrity was also com-
promised in these animals. Evans blue dye (EBD) is a small-
molecular-weight dye that fluoresces in the red channel under
UV light. Although the sarcolemma of physiologically normal
cells is impermeable to EBD, it selectively accumulates in cells
in which the sarcolemma has been torn. Injection of EBD into
the precardiac sinus results in the passage of dye through the
larval circulatory system and consequent uptake by cells with
compromised membranes. Unlike in sap fish [Fig. 2C (23)], no
uptake of EBD was seen in caf homozygotes at 72 hpf by
retracted or nonretracted fibers (Fig. 2A). On the contrary, EBD
fluorescence was seen to pool in the interfiber myotomal lesions
created by fiber retraction, indicating that sarcolemmal integrity
was maintained (Fig. 2B).
The caf teg15a and caf tk209 Alleles Map to a Region Containing the
Zebrafish Orthologue of LAMA2. A first-pass map position for
caf teg15a was established by using standard bulked segregant
analysis (24) to markers z6804 and z10056 on linkage group 20.
Using a fine mapping strategy, this region was further refined to
the flanking markers z9708 and z7603 (Fig. 3A), approximating
a genomic region of 0.89 Mb, containing 23 transcripts. In the
center of this region was a portion of the zebrafish orthologue of
laminin 2 (lama2), which in humans is causative of LAMA2-
deficient CMD. To confirm the genomic position of zebrafish
lama2, radiation hybrid mapping was carried out on the LN54
panel (25) by using gene-specific primers to a portion of the
lama2 ORF. Using this approach, significant linkage was found
to marker z6804 on linkage group 20 (one of those implicated in
the initial bulked segregant analysis).
lama2 mRNA Expression Is Reduced in Mutant Embryos. To investi-
gate lama2 as a candidate causative of the caf phenotype, we
Fig. 2. Unlike in dystrophin-deficient sap embryos, detached fibers in caf
embryos do not show uptake of EBD, indicating that the sarcolemma is not
compromised. (A) EBD within caf homozygotes is not taken up by a recently
detached fiber in a homozygous caf embryo (arrowhead). (B) EBD can be seen
to pool in a large myotomal lesion created by multiple retracting fibers
(arrowhead). Retracted fibers themselves remain impermeable to EBD (ar-
row). (C) Damaged fibers in homozygous sap embryos are infiltrated by EBD
before detachment. (D) EBD-positive retracted fiber in a sap embryo. (i)
fluorescence, (ii) DIC, and (iii) merge. All images represent 72-hpf embryos,
lateral views with anterior to the left.
Fig. 3. The cafphenotype is a result of mutations in the zebrafish homologue of the LAMA2gene. (A) Initial bulked segregant analysis implicated markers z6804
and z10056 as being linked to the caf phenotype. Further fine mapping resolved flanking markers z9708 and z7603, delineating a candidate genomic region
of0.89 Mb, containing sequence with homology to human LAMA2. Single base changes in both caf teg15a and caf tk209 were found in the homologue of human
exon 60, resulting in the introduction of premature stop codons to the zebrafish lama2 ORF. (B) In situ hybridization to the lama2 mRNA at 48 hpf shows
expression in the myotomal muscle. Strikingly, there is a severe reduction of message in caf homozygous embryos, suggestive of nonsense-mediated decay.
Brackets indicate region of myotome. (i) Homozygous caf embryo, (ii) wild-type embryo, and (iii) transverse methacrylate sections through the trunk of caf (Left)
and wild-type (Right) embryos. (C) Structure of the human LAMA2 protein. The positions of mutations that result in the MDC1A disease are indicated by black
arrowheads. The homologous positions of the cafteg15a and caf tk209 stop codons are indicated by red arrowheads. Both caf mutations occur in close proximity
to known human MDC1A mutations, within the globular domain, which is essential for dystroglycan binding. Domains represented are laminin VI (red), laminin
IV (blue), EGF-like (gray), and globular (green). (D) Amino acid alignment between zebrafish (Dr), human (Hs), and mouse (Mm) sequences for the mutant exon.
Both caf teg15a and caf tk209 mutations occur within completely conserved amino acids. (E) Injection of antisense morpholino oligonucleotides against the lama2
mRNA phenocopies the caf homozygous mutants. Seventy-two hpf, lateral view, anterior to the left.
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carried out in situ hybridization for the lama2 mRNA on caf
mutant and sib embryos (Fig. 3B). Expression of the transcript
closely follows the sites of muscle differentiation in the embryos
and larvae (Fig. 3B; SI Fig. 8), being first detected in an adaxial
cell pattern, which are the first muscle cells to differentiate and
express myofibrillar markers such as sMyHC1 (26). By 48 hpf, the
transcript is expressed predominantly in the skeletal muscle,
supporting the notion of a role in muscle cell maintenance.
Importantly, we noted that25% of embryos from an incross of
caf heterozygote parents showed a weaker staining pattern for
the lama2 expression than their siblings. At 72 hpf, this lower
level of lama2 message correlated with embryos exhibiting the
caf phenotype (n  6/20), suggesting that lama2 transcripts
undergo nonsense-mediated decay in caf homozygotes.
The caf teg15a and caf tk209 Strains Contain Stop Mutations in the lama2
ORF and Are Phenocopied by Anti-lama2 Morpholinos. The high
degree of misassembly in the genomic region necessitated rear-
rangement of the region by using the mouse and human LAMA2
amino acid sequences as references. Once a contiguous genomic
sequence was created, 55 putative coding exons of the zebrafish
lama2 gene were predicted by using Genewise (27). All putative
exons were successfully sequenced by using flanking primers
within adjacent introns. Premature stop codons were found in
the zebrafish homologue of human exon 60 in both caf teg15a and
caf tk209 (Fig. 3 A andD; GenBank accession no. EF467237). This
region encodes the globular domain of the Lama2 protein that
is essential for dystroglycan binding and is in close proximity to
human mutations causative for MDC1A (Fig. 3C). Twenty-four
affected and 24 unaffected progeny from each allele strain were
genotyped by initial restriction analysis, followed by sequencing,
demonstrating absolute segregation of the mutations with the
dystrophic phenotypes (SI Table 3).
To further demonstrate that mutations in the zebrafish lama2
gene cause a dystrophic phenotype, we injected antisense mor-
pholino oligonucleotides into the first blastomere of wild-type
embryos. MO-Lama2–1 was a translation blocking morpholino
designed to cover the initiation codon, and MO-Lama2–60 was
designed to overlap the boundary of the zebrafish homologues
of human exons 59 and 60, inducing exon skipping of exon 60 and
a frameshift in exon 61, to result in a truncated protein. Injection
of MO-Lama2–1 at 50 ng/l and MO-Lama2–60 at 10 ng/l did
not cause nonspecific abnormalities at levels above sham-
injected embryos and phenocopied the caf phenotype at 59%
(10/17) and 52% (15/29) respectively (Fig. 3E). Thus, we con-
cluded that the stop mutations we have identified in lama2 cause
the caf teg15a and caf tk209 phenotypes, respectively.
Innervation Is Unaffected in caf Embryos.One model of the cellular
pathology in LAMA2 deficiency is that innervation defects lead
to secondary muscle tissue defects such as denervation atrophy.
To investigate the effect of Lama2 deficiency on innervation in
the context of the caf model we used TRITC conjugated
bungarotoxin, which binds irreversibly to the neuromuscular
junction, and fluoresces in the red channel. In addition, we
examined the outgrowth of the primary motor neurons from the
neural tube by crossing caf embryos with a transgenic line
Tg(cmet:EGFP)ed6, which expresses EGFP in the middle pri-
mary, rostral primary, and caudal primary neurons (T.E.H. and
P.D.C., unpublished observations). Using confocal microscopy,
we detected no difference in the extent of innervation or
neuromuscular junction formation between homozygous mutant
and sibling embryos (SI Movies 2 and 3). Similarly, formation of
the primary motor neurons in homozygous caf embryos was
normal (SI Movies 4 and 5).
Fiber Detachment Occurs on the Extracellular Side of the Membrane
at the Myotendinous Junction (MTJ), Rather Than at the Sarcolemma.
The maintenance of membrane integrity in retracted fibers led
us to investigate the effects of the caf phenotype on DGC-
associated proteins at the sarcolemma. Dystrophin and -
dystroglycan (DG) proteins are known to be expressed at the
junctional sarcolemma after 36 h, and in the dystrophin-deficient
sap fish, DG remains at the MTJ during fiber detachment (23,
28). In addition, laminin 1 (l, 1, and 1) immunoreactivity is
detectable within the ECM of the vertical myoseptum at this
time (10). Dystrophin, DG, and laminin 1 expression at the
MTJ were unaffected in caf embryos. Furthermore, all epitopes
showed a retraction with the detached fiber ends (Fig. 4),
consistent with attachment failure occurring within the ECM
rather than at the sarcolemma.
lama2 Mutants Display Ultrastructural Defects at the MTJ. The ver-
tical myoseptum, dividing the trunk somites, is composed mainly
of dense collagen, and its structure and function are similar to
that of the mammalian tendon. As such, it is regarded as the
homologous or analogous tissue (29). To investigate the detach-
ment of fibers at the zebrafish MTJ, in the context of Lama2
deficiency, we used transmission electron microscopy on caf
embryos. We compared mutant and unaffected sibling embryos
at two separate periods of development, first at 72 hpf, when the
phenotype is still relatively mild, and at 120 hpf, when the









Fig. 4. Immunohistochemistry at 72 hpf shows retraction of epitopes with
detaching fibers, demonstrating that failure occurs within the extracellular
matrix rather than at the sarcolemma. (A) caf, anti-dystrophin. (B) Wild-type
anti-dystrophin. (C) caf, anti--dystroglycan. (D) Wild-type anti--dystrogly-
can. (E) caf, anti-laminin 1. (F) Wild-type anti-laminin 1. (i) Flourescence, (ii)
DIC, and (iii) merge. Arrowheads indicate retraction of epitopes with individ-
ual fibers. Images show lateral views, anterior to the left.














Under low-powered EM (2,400) at 72 hpf, the thickness and
architecture of the vertical myosepta were indistinguishable
between mutant and sibs. However, under higher magnification
(7100–54000), tearing and detachment at the myosepta were
apparent in the mutants (Fig. 5 A and B). By 120 hpf, the
myoseptal architecture in the mutant embryos was grossly
distorted. Most significantly, portions of connective tissue were
seen to infiltrate the myotome carried with the ends of retracting
fibers. The myoseptum itself was greatly expanded in thickness
and contained an irregular array of collagen fibers (Fig. 5 C
and D).
Death of Detached Fibers Is Delayed in caf Compared with sap
Embryos. In models of DMD, cells sustaining catastrophic sar-
colemmal damage are thought to undergo immediate necrosis,
whereas cells with minor damage undergo either a program of
sarcolemmal repair or apoptose. To investigate the time course
of cell death-associated DNA fragmentation in retracted fibers,
we compared caf and sap embryos by using acridine orange
staining. Acridine orange, when injected into the embryonic
circulation, is taken up by the fragmenting nuclei of cells
undergoing apoptosis/necrosis (30). caf and sap embryos were
anesthetized between 24 and 60 hpf to suppress extensive fiber
detachment. At 60 hpf, embryos were injected with acridine
orange, and severe fiber detachment was induced by using the
anesthetic recovery protocol previously described. By 72 hpf,
acridine orange positive cells were present in sap embryos, with
staining becoming extensive by 96 hpf (Fig. 6D andE). However,
in caf embryos acridine orange uptake by retracted fibers did not
occur until 96 hpf and was not extensive until 120 hpf (Fig. 6
A–C). We concluded that retracted fiber cell death is delayed in
caf embryos in comparison to sap embryos.
Discussion
In this paper, we present a zebrafish model of MDC1A and
examine the cellular phenotype with respect to three current
hypotheses, that pathology occurs because of (i) sarcolemmal
weakness, leading to loss of membrane integrity and fiber
necrosis (15); (ii) loss of Lama2-mediated signaling, leading to
defects in myoblast proliferation and fusion (21); and (iii)
effective denervation atrophy because of defects in the periph-
eral nervous system (7). We demonstrate that none of these
explanations adequately accounts for the early dystrophic muscle
phenotype in homozygous lama2-null mutant zebrafish embryos.
We believe that damage to the muscle tissue occurs by mechan-
ically induced fiber detachment in the absence of sarcolemmal
rupture, and that detached fibers undergo subsequent cell death.
Superficially, the caf and sap phenotypes have a similar
appearance, because there is no impairment of new muscle
formation [consistent with dy/dy (31) and mdx (32) phenotypes
respectively], and both involve fiber detachment. Dystrophin is
enriched both at mammalian MTJs and myomuscular junctions,
end-to-end/end-to-side muscle-to-muscle attachments that form
without intervening tendons (33). Analysis of the sap model
suggested that in larger mammalian muscles, loss of junctional
integrity at intrafascicular fiber terminations and tendinous
intersections are likely to contribute to the pathology of DMD
(23). Similarly, the caf model shows a loss of junctional integrity
at the embryonic MTJ, suggesting that Lama2 is necessary for
the stability of vertebrate muscle attachments, and that fiber
detachment is the primary cause of muscle degeneration. How-
ever, in direct contrast to the sap and other models of DMD,
where fiber detachment is associated with sarcolemmal rupture,
in caf embryos fiber detachment occurs without compromise of
membrane integrity. Attachment failure occurs within the ECM
itself, such that ECM components retract into the myotome with
the fiber. Furthermore, we find that postdetachment cell death
begins substantially later in caf compared with sap embryos.
Detached fibers in sap embryos showmore rapid acridine orange







Fig. 5. Transmission electron micrographs of the vertical myosepta in cafand
wild-type embryos at 72 and 120 hpf. (A) caf, 72 hpf. The extracellular matrix
phenotype is subtle and under low magnification (i; 2,400) the myosepta
appear normal. However, under higher magnification (ii; 7,100 and iii;
54,000), tearing of the myosepta can be seen that is not apparent in
wild-type siblings (arrowheads). (B) Wild-type, 72 hpf. (C) caf, 120 hpf. Even
under low magnification, the myosepta are grossly distorted and fibrotic.
Under medium magnification, portions of extracellular matrix can be seen to
infiltrate the myotome (arrowhead), pulled with the detaching fibers. Under
high magnification, the myosepta are greatly increased in diameter and show

















Fig. 6. Cell death after artificially induced fiber detachment is delayed in caf
embryos when compared with dystrophin-deficient sap embryos. Fiber de-
tachment was induced at 60 hpf and the time course of cell death followed by
using acridine orange. Acridine orange uptake by apoptotic/necrotic cells is
first seen at 72 hpf in sap embryos but not until 96 hpf in caf embryos. In
addition, uptake does not peak until 120 hpf in caf embryos compared with 96
hpf in sap. (A–C) caf, 72–120 hpf. (D and E) sap, 72–96 hpf. Time-lapse analysis
of acridine orange uptake between 60 and 72 hpf on individual embryos
confirms uptake in sap, but not in caf embryos. (F and G) Images show epaxial
somites, anterior to the left. Time-lapse movies are available as SI Movies 6
and 7.
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These observations provide a mechanistic explanation for
previous studies in the Lama2-deficient dy/dymouse, which show
lower EBD accumulation in the skeletal muscles than the mdx
mouse (34) and, furthermore, that down-regulation of the
proapoptosis factor Bax or up-regulation of the antiapoptosis
protein Bcl2, results in amelioration of the dystrophic phenotype
(35, 36). Importantly, the same treatment appears to produce no
effect in the mdx mouse. It can be envisaged that, in the case of
fiber retraction without loss of membrane integrity, a retracted
cell would remain in a viable but afunctional state and would
undergo subsequent apoptosis. Amelioration of the Lama2-
deficient phenotype might then occur either by tempering the
inflammatory response, which is known to exacerbate dystrophic
pathology (37), or by fiber reattachment during subsequent
tissue growth. However, our model suggests that muscle atrophy
is driven primarily by the absence of functional connections with
the ECM rather than by apoptosis itself. The understanding of
such mechanisms will likely implicate new targets for gene
therapy and for therapeutic drugs.
Zebrafish models of disease are particularly valuable because
they develop ex utero and are optically clear, highly manipulable,
and genetically tractable. We show direct visual observations of
the pathology of muscular dystrophy by using time-lapse pho-
tomicroscopy in a manner hitherto impossible in other animal
models of muscle disease. This makes possible a number of
avenues of investigation. Until now, the only zebrafish model of
muscular dystrophy has been the sap model of DMD, which is
progressive and homozygous lethal. Consistent with human
MDC1A, we have shown that caf zebrafish, despite an initially
more severe phenotype, can reach adulthood in the homozygous
state. This presents opportunity for the study of later phenotypes
such as CNS and peripheral nerve effects (38) and cardiac
involvement, which has been implicated in MDC1A (39).
Materials and Methods
Bulked segregant analysis and mapping were performed accord-
ing to current protocols (24). Antibody staining was performed
as described (28), with the exception of anti-laminin 1, for which
methanol fixation was used in place of 4% paraformaldehyde in
PBS. Primary antibodies used were anti-dystrophin MANDRA
(Sigma, St. Louis, MO), anti- dystroglycan 7D11 (Develop-
mental Studies Hybridoma Bank, Iowa City, IA), anti-laminin 1
(Sigma). Alexa-labeled secondary antibodies were diluted 1:200.
In situ hybridization was performed as described, as was the use
of TRITC-conjugated bungarotoxin (23). Evans blue (23), acri-
dine orange (30), and morpholino injections (28) were per-
formed as described. For electronmicrographs, we used a Philips
(Eindhoven, The Netherlands) EM410 transmission electron
microscope. Samples were fixed in 2.5% glutaraldehyde and
embedded in Spurr’s resin. For production of transgenic lines
(40), a 5.5-kb region upstream of the cmet promoter was
amplified by PCR, fused to a GAL4-UAS-EGFP reporter, and
placed into the pT2XIGin plasmid. Additional details are
provided in SI Materials and Methods.
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